Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 20, 2013

Advaxis, Amgen, Cornerstone CytRx, Daiichi Sankyo, Genzyme, Sanofi, Zealand

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II Advaxis starts HPV cancer trial . . . read more Amgen presents PCSK9 LDL results . . . read more CytRx starts GBM trial . . . read more Zealand begins danegaptide POC trial . . . read more Phase III Daiichi’s edoxaban exceeds warfarin targets . . . read more Filings Health Canada approves Sanofi’s Aubagio . . . read more Launches Cornerstone launches Bethkis for CF . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters